Related Experiment Videos
[Ascites inaugurating systemic mastocytosis (author's transl)]
Annales De Medecine Interne
|January 1, 1981
Summary
Urticaria pigmentosa with systemic mastocytosis can present with ascites, a rare manifestation. Treatment involves histamine inhibitors and disodium cromoglycate, but prognosis can be poor due to potential complications.
Area of Science:
- Hematology
- Dermatology
- Gastroenterology
Background:
- Urticaria pigmentosa is a rare condition characterized by mast cell infiltration.
- Systemic mastocytosis involves widespread mast cell proliferation, potentially affecting multiple organs.
- Ascites is an uncommon but significant finding in systemic mastocytosis.
Observation:
- A case of urticaria pigmentosa with systemic mastocytosis presented with ascites.
- Diagnosis was confirmed by diffuse mast cell infiltration in the bone marrow.
- Hypersecretion of histamine by mast cells was identified as a key factor.
Findings:
- Ascites in this context remains poorly understood.
- Histamine inhibitors and disodium cromoglycate showed symptomatic efficacy.
- The condition carries a poor prognosis due to risks of leukemia, carcinoma, and bleeding.
Implications:
- Highlights the importance of recognizing rare manifestations like ascites in systemic mastocytosis.
- Suggests potential therapeutic strategies targeting histamine pathways.
- Underscores the need for vigilant monitoring for severe complications and poor prognosis.